Thus, AKT inhibition by PML::RARα, with inefficient primary cytoplasmic glycolysis and subsequent pyruvate scarcity must be the cause of the inability to utilize the glycolytic pathway for APL’s cells metabolic needs. This evidence concerns the gene RARA and acute promyelocytic leukemia.